Healthcare / Medical DistributionNYSE
$2.77
-0.07 (-2.46%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-21.2M · quality 47.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$212M
P/E
N/A
•EV/EBITDA
9.3x
↓ROE
238.8%
↑Gross Margin
46.7%
↓Debt/Equity
-4.60
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
-5.5%
FCF CAGR
—
FCF margin
-11.0%
FCF / Net income
0.28x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.76B · net income $-1.10B · FCF $-303.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $2.76B | $2.76B | $2.68B | $2.55B | $9.96B | $9.79B | $8.48B | $9.21B | $9.42B | $9.32B | $9.72B | $9.77B | $9.44B | $9.07B | $8.87B | $8.63B | $8.12B | $8.04B | $7.24B |
| Net Income | $-1.10B | $-1.10B | $-362.7M | $-41.3M | $22.4M | $221.6M | $29.9M | $-62.4M | $-437.0M | $72.8M | $108.8M | $103.4M | $66.5M | $110.9M | $109.0M | $115.2M | $110.6M | $104.7M | $93.3M |
| EBITDA | $219.8M | $219.8M | $-41.0M | $342.4M | $368.4M | $459.1M | $297.5M | $189.8M | $-250.4M | $148.7M | $255.0M | $266.3M | $222.9M | $248.7M | $236.4M | $237.7M | $225.1M | $226.5M | $202.7M |
| EPS | -14.31 | -14.31 | -4.73 | -0.54 | 0.29 | 2.94 | 0.47 | -1.03 | — | — | 1.76 | 1.65 | 1.06 | 1.76 | 1.72 | 1.81 | 1.75 | 1.67 | 1.50 |
| Gross Margin | 46.7% | 46.7% | 47.8% | 47.7% | 18.3% | 15.5% | 15.1% | 12.3% | 11.4% | 12.6% | 12.2% | 12.4% | 12.4% | 12.3% | 10.4% | 9.9% | 9.9% | 10.1% | 10.2% |
| Operating Margin | 8.0% | 8.0% | 7.4% | 8.4% | 2.8% | 3.8% | 2.4% | 0.8% | -3.7% | 1.0% | 2.1% | 2.1% | 1.7% | 2.2% | 2.2% | 2.4% | 2.4% | 2.5% | 2.5% |
| Net Margin | -39.8% | -39.8% | -13.5% | -1.6% | 0.2% | 2.3% | 0.4% | -0.7% | -4.6% | 0.8% | 1.1% | 1.1% | 0.7% | 1.2% | 1.2% | 1.3% | 1.4% | 1.3% | 1.3% |
| Balance Sheet | |||||||||||||||||||
| Debt/Equity | -4.60 | -4.60 | 3.29 | 2.51 | 2.87 | — | 1.38 | 3.26 | 3.18 | 0.89 | — | — | 0.61 | 0.21 | 0.22 | 0.23 | 0.24 | — | — |
| Current Ratio | 0.49 | 0.49 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | $-303.1M | $-303.1M | $-21.2M | $562.2M | $158.4M | $83.2M | $288.8M | $123.7M | $70.7M | $22.2M | $167.4M | $249.7M | $-52.2M | $112.4M | — | — | — | — | — |
| Returns | |||||||||||||||||||
| ROE | 238.8% | 238.8% | -61.9% | -4.5% | 2.4% | 23.6% | 4.2% | -13.5% | -84.3% | 7.2% | — | — | 6.7% | 10.8% | 11.2% | 12.5% | 12.9% | 13.6% | 13.5% |
| Valuation | |||||||||||||||||||
| P/E | — | — | — | — | 68.86 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 9.33 | 9.33 | — | 10.31 | 11.31 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | — | — | 1.71 | 1.57 | 1.61 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | 3.1% | 3.1% | 5.0% | -74.4% | — | 15.4% | -7.9% | -2.2% | 1.1% | -4.2% | -0.5% | 3.5% | 4.1% | 2.3% | 2.8% | 6.2% | 1.1% | 11.0% | — |
| EPS Growth | -202.5% | -202.5% | -775.9% | -286.2% | — | 525.5% | 145.6% | — | — | — | 6.7% | 55.7% | -39.8% | 2.3% | -5.0% | 3.4% | 4.8% | 11.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-58.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-4.73 → -14.31
Residual
-58.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.